000			01819nam a2200421 i 4500
999			_c279856 _d279856
001			on1088559297
003			OCoLC
005			20190318151647.0
006			m o d f
007			cr bn||||a||||
008			190227s2019 dcua ob f000 0 eng c
040			_aPUCPR _beng _erda _epn _cGPO _dMvI
042			_apcc
043			_an-us---
074			_a1019-C-01 (online)
086	0		_aY 4.C 73/8:115-126
088			_aSerial no. 115-126 (United States. Congress. House. Committee on Energy and Commerce)
099			_aY 4.C 73/8:115-126
110	1		_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce. _bSubcommittee on Health,
245	1	0	_aImproving the coordination and quality of substance use disorder treatment : _bhearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, May 8, 2018.
264		1	_aWashington : _bU.S. Government Publishing Office, _c2019.
300			_a1 online resource (vi, 313 pages) : _billustrations
336			_btxt
337			_bc _2rdamedia
338			_bcr _2rdacarrier
500			_a"Serial No. 115-126."
500			_aCRDP Program record.
504			_aIncludes bibliographical references.
588			_aDescription based on online resource, PDF version; title from title page (govinfo, viewed Feb. 27, 2019).
856	4	0	_uhttps://purl.fdlp.gov/GPO/gpo116739
050		4	_aKF27 _b.E553 2018h
650		0	_aDrugs _xOverdose _xTreatment _zUnited States.
650		0	_aDrugs _xOverdose _zUnited States _xPrevention.
650		0	_aOpioids _xOverdose _zUnited States _xPrevention.
650		0	_aOpioid abuse _zUnited States _xPrevention.
655		7	_aLegislative hearings. _2lcgft
942			_2sudocs _c8